1GLOBE BIOMEDICAL CO., LTD.
10Patents
10Active
10Granted
47Portfolio score
Filing activity: Jul 25, 2013 → Nov 27, 2019
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9481884B2 | Enabling the use of long dsRNA for gene targeting in mammalian and other selected animal cells | Chemistry; Metallurgy | 2 | Active |
| US11370748B2 | Therapeutics for central nervous system disorders | Human Necessities | 0 | Active |
| US11667693B2 | Synthetic biology-based ADCC technology | Chemistry; Metallurgy | 0 | Active |
| US12378295B2 | Rationally designed protein compositions | Chemistry; Metallurgy | 0 | Active |
| US12390460B2 | Treatment for obesity | Chemistry; Metallurgy | 0 | Active |
| US12318381B2 | Treatment for non-alcoholic fatty liver disease | Chemistry; Metallurgy | 0 | Active |
| US12257227B2 | Combination solution for treating chemotherapy refractory cancer | Human Necessities | 0 | Active |
| US12247062B2 | Soluble universal ADCC-enhancing synthetic fusion gene and peptide technology and its use thereof | Chemistry; Metallurgy | 0 | Active |
| US12391758B2 | Anti-PD-L1 cancer immunotherapy antibodies | Chemistry; Metallurgy | 0 | Active |
| US10526392B2 | Synthetic biology-based ADCC technology | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.